vs
Absci Corp（ABSI）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是Absci Corp的1.4倍（$901.0K vs $650.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -4548.0%，领先4399.7%），Absci Corp同比增速更快（-2.3% vs -25.8%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -6.5%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
ABSI vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.4倍
$650.0K
营收增速更快
ABSI
高出23.6%
-25.8%
净利率更高
RKDA
高出4399.7%
-4548.0%
两年增速更快
RKDA
近两年复合增速
-6.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $901.0K |
| 净利润 | $-29.6M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -4775.5% | -152.8% |
| 净利率 | -4548.0% | -148.3% |
| 营收同比 | -2.3% | -25.8% |
| 净利润同比 | -2.0% | 67.1% |
| 每股收益（稀释后） | $-0.19 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSIRKDA
| Q4 25 | $650.0K | $901.0K | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | $593.0K | $1.5M | ||
| Q1 25 | $1.2M | $1.2M | ||
| Q4 24 | $665.0K | $1.2M | ||
| Q3 24 | $1.7M | $1.5M | ||
| Q2 24 | $1.3M | $1.3M | ||
| Q1 24 | $898.0K | $987.0K |
净利润ABSIRKDA
| Q4 25 | $-29.6M | $-1.3M | ||
| Q3 25 | — | $856.0K | ||
| Q2 25 | $-30.6M | $-4.5M | ||
| Q1 25 | $-26.3M | $2.6M | ||
| Q4 24 | $-29.0M | $-4.1M | ||
| Q3 24 | $-27.4M | $-1.6M | ||
| Q2 24 | $-24.8M | $1.1M | ||
| Q1 24 | $-22.0M | $-2.4M |
毛利率ABSIRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率ABSIRKDA
| Q4 25 | -4775.5% | -152.8% | ||
| Q3 25 | — | -88.5% | ||
| Q2 25 | -5293.9% | -34.4% | ||
| Q1 25 | -2351.9% | 44.2% | ||
| Q4 24 | -4477.3% | -187.7% | ||
| Q3 24 | -1698.7% | -114.5% | ||
| Q2 24 | -2104.0% | — | ||
| Q1 24 | -2616.7% | -160.9% |
净利率ABSIRKDA
| Q4 25 | -4548.0% | -148.3% | ||
| Q3 25 | — | 65.7% | ||
| Q2 25 | -5155.0% | -306.4% | ||
| Q1 25 | -2234.6% | 216.6% | ||
| Q4 24 | -4358.3% | -334.5% | ||
| Q3 24 | -1610.7% | -104.9% | ||
| Q2 24 | -1948.8% | 81.2% | ||
| Q1 24 | -2447.1% | -245.5% |
每股收益（稀释后）ABSIRKDA
| Q4 25 | $-0.19 | $-0.97 | ||
| Q3 25 | — | $0.62 | ||
| Q2 25 | $-0.24 | $-3.26 | ||
| Q1 25 | $-0.21 | $1.90 | ||
| Q4 24 | $-0.26 | $-2.99 | ||
| Q3 24 | $-0.24 | $-1.18 | ||
| Q2 24 | $-0.22 | $0.78 | ||
| Q1 24 | $-0.22 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $189.4M | $4.1M |
| 总资产 | $216.3M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABSIRKDA
| Q4 25 | $144.3M | $4.6M | ||
| Q3 25 | — | $5.9M | ||
| Q2 25 | $38.0M | $4.4M | ||
| Q1 25 | $47.0M | $3.2M | ||
| Q4 24 | $112.4M | $4.2M | ||
| Q3 24 | $38.2M | $6.6M | ||
| Q2 24 | $42.9M | $8.1M | ||
| Q1 24 | $58.8M | $8.5M |
总债务ABSIRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABSIRKDA
| Q4 25 | $189.4M | $4.1M | ||
| Q3 25 | — | $5.4M | ||
| Q2 25 | $173.4M | $4.5M | ||
| Q1 25 | $198.8M | $8.9M | ||
| Q4 24 | $179.1M | $6.2M | ||
| Q3 24 | $201.3M | $10.3M | ||
| Q2 24 | $221.5M | $11.7M | ||
| Q1 24 | $240.1M | $10.6M |
总资产ABSIRKDA
| Q4 25 | $216.3M | $6.5M | ||
| Q3 25 | — | $8.6M | ||
| Q2 25 | $209.9M | $7.8M | ||
| Q1 25 | $232.4M | $13.0M | ||
| Q4 24 | $213.6M | $13.5M | ||
| Q3 24 | $235.2M | $15.2M | ||
| Q2 24 | $255.5M | $17.4M | ||
| Q1 24 | $274.9M | $16.0M |
负债/权益比ABSIRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | — |
| 自由现金流率自由现金流/营收 | -4505.4% | — |
| 资本支出强度资本支出/营收 | 15.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-85.2M | — |
8季度趋势，按日历期对齐
经营现金流ABSIRKDA
| Q4 25 | $-29.2M | $-861.0K | ||
| Q3 25 | — | $-257.0K | ||
| Q2 25 | $-16.9M | $-2.0M | ||
| Q1 25 | $-21.8M | $-1.6M | ||
| Q4 24 | $-17.0M | $-2.2M | ||
| Q3 24 | $-20.7M | $-1.8M | ||
| Q2 24 | $-16.8M | $-2.5M | ||
| Q1 24 | $-17.9M | $-3.2M |
自由现金流ABSIRKDA
| Q4 25 | $-29.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-17.1M | — | ||
| Q1 25 | $-21.9M | — | ||
| Q4 24 | $-17.0M | — | ||
| Q3 24 | $-20.8M | — | ||
| Q2 24 | $-17.2M | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率ABSIRKDA
| Q4 25 | -4505.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -2883.0% | — | ||
| Q1 25 | -1854.5% | — | ||
| Q4 24 | -2554.4% | — | ||
| Q3 24 | -1221.6% | — | ||
| Q2 24 | -1352.4% | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度ABSIRKDA
| Q4 25 | 15.8% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 37.6% | 0.0% | ||
| Q1 25 | 2.1% | 0.0% | ||
| Q4 24 | 3.5% | 0.0% | ||
| Q3 24 | 2.8% | 0.0% | ||
| Q2 24 | 26.2% | 0.2% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率ABSIRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
